Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)

NCT05685004 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme of Brain

Interventions

BIOLOGICAL: TVI-Brain-1
PROCEDURE: Standard of Care
RADIATION: Radiotherapy
DRUG: Temozolomide

Sponsor

TVAX Biomedical